POWRESI Trademark
Trademark Overview
On Friday, September 29, 2017, a trademark application was filed for POWRESI with the United States Patent and Trademark Office. The USPTO has given the POWRESI trademark a serial number of 79226083. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Tuesday, May 27, 2025. This trademark is owned by Astellas Pharma Inc.. The POWRESI trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, oncological, ophthalmological, peripheral nervous system, psychiatric, renal, respiratory, urogenital, urological, osteopathic, hematological, pulmonary and viral diseases and disorders; pharmaceutical preparations for the treatment pain and diabetes; pharmaceutical preparations for use in regenerative medicine; pharmaceutical preparations, namely, antibacterial preparations, antifungal preparations, antiviral preparations, dermatological preparations, immunosuppressants, and tissue repair preparations; vaccines
General Information
| Serial Number | 79226083 |
| Word Mark | POWRESI |
| Filing Date | Friday, September 29, 2017 |
| Status | 709 - CANCELLED - SECTION 71 |
| Status Date | Tuesday, May 27, 2025 |
| Registration Number | 5478119 |
| Registration Date | Tuesday, May 29, 2018 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 13, 2018 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, oncological, ophthalmological, peripheral nervous system, psychiatric, renal, respiratory, urogenital, urological, osteopathic, hematological, pulmonary and viral diseases and disorders; pharmaceutical preparations for the treatment pain and diabetes; pharmaceutical preparations for use in regenerative medicine; pharmaceutical preparations, namely, antibacterial preparations, antifungal preparations, antiviral preparations, dermatological preparations, immunosuppressants, and tissue repair preparations; vaccines |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | F - NOT AVAILABLE |
| Class Status Date | Tuesday, May 27, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Astellas Pharma Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Chuo-ku, Tokyo 103-8411
JP |
| Party Name | Astellas Pharma Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
| Party Name | Astellas Pharma Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | JP |
Trademark Events
| Event Date | Event Description |
| Friday, February 2, 2018 | LIMITATION FROM ORIGINAL APPLICATION ENTERED |
| Thursday, February 1, 2018 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Tuesday, July 10, 2018 | FINAL DISPOSITION NOTICE SENT TO IB |
| Wednesday, February 7, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, February 7, 2018 | ASSIGNED TO EXAMINER |
| Wednesday, February 7, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, February 13, 2018 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, February 21, 2018 | NOTICE OF PUBLICATION |
| Tuesday, March 13, 2018 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 29, 2018 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, June 28, 2018 | GRANT OF PROTECTION CREATED, TO BE SENT TO IB |
| Monday, July 9, 2018 | FINAL DISPOSITION PROCESSED |
| Friday, July 30, 2021 | NEW REPRESENTATIVE AT IB RECEIVED |
| Friday, June 3, 2022 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Friday, June 3, 2022 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Friday, June 3, 2022 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Friday, June 3, 2022 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, June 3, 2022 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Friday, June 3, 2022 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Friday, July 27, 2018 | NOTIFICATION PROCESSED BY IB |
| Saturday, June 25, 2022 | NEW REPRESENTATIVE AT IB RECEIVED |
| Monday, May 29, 2023 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Tuesday, July 9, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, October 25, 2024 | TEAS SECTION 71 & 15 RECEIVED |
| Tuesday, July 9, 2024 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |
| Tuesday, July 9, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, July 9, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, July 9, 2024 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
| Monday, October 28, 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Monday, November 4, 2024 | OFFICE ACTION ISSUED POU1 |
| Tuesday, May 27, 2025 | CANCELLED SECTION 71 |
| Tuesday, May 27, 2025 | CANCELLED SECTION 71 |
| Tuesday, May 27, 2025 | NOTICE OF CANCELLATION SEC. 71 E-MAILED |
| Tuesday, May 27, 2025 | NOTICE OF CANCELLATION SEC. 71 E-MAILED |
